UY28864A1 - Derivados de piridoindolona substituidos en -6, su preparación y su aplicación en terapéutica. - Google Patents

Derivados de piridoindolona substituidos en -6, su preparación y su aplicación en terapéutica.

Info

Publication number
UY28864A1
UY28864A1 UY28864A UY28864A UY28864A1 UY 28864 A1 UY28864 A1 UY 28864A1 UY 28864 A UY28864 A UY 28864A UY 28864 A UY28864 A UY 28864A UY 28864 A1 UY28864 A1 UY 28864A1
Authority
UY
Uruguay
Prior art keywords
group
therapeutics
preparation
application
substituted
Prior art date
Application number
UY28864A
Other languages
English (en)
Inventor
Bourrie Bernard
Casellas Pierre
Derocq Jean Marie
Jegham Samir
Muneaux Yvette
Wermuth Camille Georges
Ciapetti Paola
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of UY28864A1 publication Critical patent/UY28864A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)

Abstract

La presente invención tiene por objeto compuestos que responden a la fórmula : en la cual: - R1 representa un átomo de hidrógeno; un grupo alquilo (C1-C4); un grupo -(CH2)mOH; un grupo -(CH2)mCN; un grupo -(CH2)mNR9R10; - R2 representa un átomo de hidrógeno o un grupo alquilo (C1-C4); - R3 representa un fenilo substituido por R6, R7, R8; - R4 representa : R11 . un grupo -C=N-OR12; .un grupo heterocíclico elegido entre: - R5 representa un átomo de hidrógeno o un grupo alquilo (C1-C4). Procedimiento de preparación y aplicación en terapéutica.
UY28864A 2004-04-21 2005-04-21 Derivados de piridoindolona substituidos en -6, su preparación y su aplicación en terapéutica. UY28864A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0404251A FR2869316B1 (fr) 2004-04-21 2004-04-21 Derives de pyridoindolone substitues en -6, leur preparation et leur application en therapeutique.

Publications (1)

Publication Number Publication Date
UY28864A1 true UY28864A1 (es) 2005-11-30

Family

ID=34945552

Family Applications (1)

Application Number Title Priority Date Filing Date
UY28864A UY28864A1 (es) 2004-04-21 2005-04-21 Derivados de piridoindolona substituidos en -6, su preparación y su aplicación en terapéutica.

Country Status (31)

Country Link
US (1) US7812165B2 (es)
EP (1) EP1742947B1 (es)
JP (1) JP4809830B2 (es)
KR (1) KR20070002094A (es)
CN (1) CN100537568C (es)
AR (1) AR048932A1 (es)
AT (1) ATE405565T1 (es)
AU (1) AU2005240816A1 (es)
BR (1) BRPI0510060A (es)
CA (1) CA2562561A1 (es)
CR (1) CR8677A (es)
DE (1) DE602005009166D1 (es)
DK (1) DK1742947T3 (es)
EC (1) ECSP066918A (es)
ES (1) ES2313371T3 (es)
FR (1) FR2869316B1 (es)
HK (1) HK1106223A1 (es)
IL (1) IL178444A0 (es)
MA (1) MA28546B1 (es)
MX (1) MXPA06012127A (es)
MY (1) MY137599A (es)
NO (1) NO20065323L (es)
PL (1) PL1742947T3 (es)
PT (1) PT1742947E (es)
RU (1) RU2364595C2 (es)
TN (1) TNSN06337A1 (es)
TW (1) TW200538114A (es)
UA (1) UA85709C2 (es)
UY (1) UY28864A1 (es)
WO (1) WO2005108398A1 (es)
ZA (1) ZA200608646B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2823975B1 (fr) 2001-04-27 2003-05-30 Sanofi Synthelabo Nouvelle utilisation de pyridoindolone
FR2846329B1 (fr) 2002-10-23 2004-12-03 Sanofi Synthelabo Derives de pyridoindolone substitues en -3 par un phenyle, leur preparation et leur application en therapeutique
US7456193B2 (en) 2002-10-23 2008-11-25 Sanofi-Aventis Pyridoindolone derivatives substituted in the 3-position by a heterocyclic group, their preparation and their application in therapeutics
FR2892416B1 (fr) * 2005-10-20 2008-06-27 Sanofi Aventis Sa Derives de 6-heteroarylpyridoindolone, leur preparation et leur application en therapeutique

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1268772A (en) 1968-03-15 1972-03-29 Glaxo Lab Ltd NOVEL alpha-CARBOLINE DERIVATIVES, THE PREPARATION THEREOF AND COMPOSITIONS CONTAINING THE SAME
US4263304A (en) * 1978-06-05 1981-04-21 Sumitomo Chemical Company, Limited 7 H-indolo[2,3-c]isoquinolines
SU833971A1 (ru) 1979-07-10 1981-05-30 Ленинградский Химико-Фармацевтическийинститут Способ получени 3-фенил-2-оксо- - КАРбОлиНОВ
FR2595701B1 (fr) * 1986-03-17 1988-07-01 Sanofi Sa Derives du pyrido-indole, leur application a titre de medicaments et les compositions les renfermant
JPH10501686A (ja) 1994-04-13 1998-02-17 ザ ロックフェラー ユニヴァーシティ 神経系の細胞へのｄｎａのａａｖ仲介送達
DE19502753A1 (de) * 1995-01-23 1996-07-25 Schering Ag Neue 9H-Pyrido[3,4-b]indol-Derivate
FR2765582B1 (fr) 1997-07-03 1999-08-06 Synthelabo Derives de 3-alkyl-1,9-dihydro-2h-pyrido[2,3-b]indol-2-one leur preparation et leur application en therapeutique
FR2765581B1 (fr) * 1997-07-03 1999-08-06 Synthelabo Derives de 3-aryl-1,9-dihydro-2h-pyrido[2,3-b]indol-2-one, leur preparation et leur application en therapeutique
CA2326319A1 (en) 1998-04-02 1999-10-14 Neurogen Corporation Aminoalkyl substituted 5,6,7,8-tetrahydro-9h pyrimidino[2,3-b]indole and 5,6,7,8-tetrahydro-9h-pyrimidino[4,5-b]indole derivatives: crf1 specific ligands
IT1313592B1 (it) 1999-08-03 2002-09-09 Novuspharma Spa Derivati di 1h-pirido 3,4-b indol-1-one.
US20020156016A1 (en) 2001-03-30 2002-10-24 Gerald Minuk Control of cell growth by altering cell membrane potentials
FR2823975B1 (fr) * 2001-04-27 2003-05-30 Sanofi Synthelabo Nouvelle utilisation de pyridoindolone
FR2846330B1 (fr) 2002-10-23 2004-12-03 Sanofi Synthelabo Derives de pyridoindolone substitues en -3 par groupe heterocyclique, leur preparation et leur application en therapeutique
US7456193B2 (en) * 2002-10-23 2008-11-25 Sanofi-Aventis Pyridoindolone derivatives substituted in the 3-position by a heterocyclic group, their preparation and their application in therapeutics
FR2846329B1 (fr) * 2002-10-23 2004-12-03 Sanofi Synthelabo Derives de pyridoindolone substitues en -3 par un phenyle, leur preparation et leur application en therapeutique
FR2892416B1 (fr) * 2005-10-20 2008-06-27 Sanofi Aventis Sa Derives de 6-heteroarylpyridoindolone, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
JP4809830B2 (ja) 2011-11-09
KR20070002094A (ko) 2007-01-04
MA28546B1 (fr) 2007-04-03
FR2869316A1 (fr) 2005-10-28
EP1742947A1 (fr) 2007-01-17
CA2562561A1 (fr) 2005-11-17
NO20065323L (no) 2006-12-08
HK1106223A1 (en) 2008-03-07
ES2313371T3 (es) 2009-03-01
RU2006140998A (ru) 2008-05-27
AR048932A1 (es) 2006-06-14
CN1956986A (zh) 2007-05-02
MXPA06012127A (es) 2007-01-31
US20070129365A1 (en) 2007-06-07
BRPI0510060A (pt) 2007-10-16
FR2869316B1 (fr) 2006-06-02
MY137599A (en) 2009-02-27
IL178444A0 (en) 2007-02-11
JP2007533710A (ja) 2007-11-22
CR8677A (es) 2007-08-28
CN100537568C (zh) 2009-09-09
WO2005108398A1 (fr) 2005-11-17
RU2364595C2 (ru) 2009-08-20
DE602005009166D1 (de) 2008-10-02
ZA200608646B (en) 2008-02-27
ATE405565T1 (de) 2008-09-15
AU2005240816A1 (en) 2005-11-17
TW200538114A (en) 2005-12-01
US7812165B2 (en) 2010-10-12
TNSN06337A1 (en) 2008-02-22
UA85709C2 (ru) 2009-02-25
PT1742947E (pt) 2008-11-25
ECSP066918A (es) 2007-01-26
PL1742947T3 (pl) 2009-01-30
DK1742947T3 (da) 2009-01-05
EP1742947B1 (fr) 2008-08-20

Similar Documents

Publication Publication Date Title
UY29047A1 (es) Derivados de sulfonamidas, su preparación y su aplicación en terapéutica
ECSP066695A (es) Derivados de n-(1,5-difenil-1h-pirazol-3-il) sulfonamida con afinidad por los receptores cb1
DOP2006000045A (es) Derivados del (1,5-difenil-1h-pirazol-3-il oxadiazol, su preparacion y su aplicacion en terapeutica
DOP2006000043A (es) Derivados del 1,5-diarilpirrol, su preparación y su aplicación en terapeútica
RS52780B (en) MEANS OF PREVENTION AND TREATMENT OF DISORDERS CONCERNING MODULATION OF RYR RECEPTORS
ME01421B (me) 5-supstituisani derivati kinazolinona kao protivtumorska sredstva
AR072224A1 (es) Derivados de pirimidona sustituidos
EA201690019A1 (ru) Производное аминотриазина и содержащая его фармацевтическая композиция
BRPI0411528A (pt) uso de isomalte como prebiótico
NO20071642L (no) N-Benzensulfonylsubstituerte anilino-pyrimidinanaloger
PA8639301A1 (es) Derivados de piridio-pirimidina, su preparacion, su enterapeutica
ATE467632T1 (de) Pyrroloä2,3-büpyridinderivate als modulatoren des h3-rezeptors
DE602006010738D1 (de) Pyrroloä2,3-cüpyridinderivate
UY30009A1 (es) Compuestos benzoilpirazol y herbicidas que los contienen
CO6251235A2 (es) Compuestos derivados de azetidinas su preparacion y su aplicacion en terapeutica
DOP2007000067A (es) Derivados de aminometilpiridina, su preparación y su aplicación en terapéutica
UY28864A1 (es) Derivados de piridoindolona substituidos en -6, su preparación y su aplicación en terapéutica.
CR9873A (es) Derivados de 6-heteroarilpiridoindolona, su preparacion y su aplicacion en terapeutica
SV2007002580A (es) Derivados del 4,5-diarilpirrol, su preparacion y su aplicacion en terapeutica
UY29054A1 (es) Derivados de pirro, su preparación y su aplicación en terapeutica
UY29048A1 (es) Oxazolidinonas que contienen oxindoles como agentes antibacterianos
AR053116A1 (es) Derivados de la n-(( 4,5-difenil-2- tienil)metil)sulfonamida,su preparacion y su aplicacion en terapeutica
GT200600122A (es) Novedosos derivados de triazolopirimidina
UY29022A1 (es) Derivados de 4 - arilmorfolin - 3 - ona, su preparacinn y su aplicacinn en terapeutica.-
UY29452A1 (es) 7-fluoro-1,3-dihidro-indol-2-ona oxazolidinonas como agentes antibacterianos

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20160617